Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: SPTBN1 abrogates renal clear cell carcinoma progression via glycolysis reprogramming in a GPT2-dependent manner

Fig. 2

SPTBN1 down-regulation predicted advanced stage and poor survival of ccRCC. A Down-regulated SPTBN1 mRNA expression level was correlated with an advanced ccRCC stage B Univariate and multivariate cox regression analysis revealed SPTBN1 as an independent prognostic factor for ccRCC patients’ survival. C The nomogram for SPTBN1 and other clinical information. D Low SPTBN1 expression level predicted worse OS, DSS and PFI in the TCGA-KIRC cohort. E Landscape of tissue microarray staining for SPTBN1 in the NJMU ccRCC cohort 2 (N = 180). F The Kaplan–Meier survival curves of patients stratified by SPTBN1 expression level

Back to article page